Ilan Feuchtwang reports a stock award at Cytek Biosciences
By AlphaYouPublished Form 4
Feuchtwang Ilan
Reporting filer
Ilan Feuchtwang reports a stock award, not an open-market purchase or sale, in Cytek Biosciences, Inc.. Form 4 filed Nov 13, 2026 lists 1 entry.
- Disclosed
- Nov 13, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (derivative) | Feuchtwang Ilan | 2026-11-09 | A | Grant or award | 25745 | 0 | 25,745 | 4 days | Filed terms
|
Restricted Stock Units (derivative)
- Owner
- Feuchtwang Ilan
- Date
- 2026-11-09
- Code
- A
- Action
- Grant or award
- Quantity
- 25745
- Price
- 0
- Following holdings
- 25,745
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F1
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 25745
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- id: F2
- underlying Security Title: Common Stock
- underlying Security Shares: 25745
- shares Owned Following Transaction: 25745
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Feuchtwang Ilan: Chief Legal Officer, Secretary.
- F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2: The RSUs shall vest and settle into common stock over 4 years, with 12/48 of the RSUs vesting on November 18, 2027; 4/48 of the RSUs vesting on March 10, 2028 and each March 10 thereafter; 2/48 of the RSUs vesting on May 18, 2028 and each May 18 thereafter; 3/48 of the RSUs vesting on August 18, 2028 and each August 18 thereafter, and 3/48 of the RSUs vesting on November 18, 2028 and each November 18 thereafter, until fully vested (in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan (the "2021 Plan"))).
Original sources
Prepared automatically from public filing data. Report a correction.